Immunophenotyping for COVID-19 Cohort (IMPACC)
Immunophenotyping for COVID-19 Cohort (IMPACC)
批准号:
10265706
负责人:
David A. Hafler
金额:
$114.92万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-05-15 至 2023-11-30
关键词:
AgeAntiviral AgentsArbovirusesBioinformaticsBiologicalBiological ModelsBloodBorrelia burgdorferiCOVID-19Cell physiologyCellsClinicClinicalCollaborationsCollectionCommunicable DiseasesComplementComplexCulicidaeDataData AnalysesDiseaseDisease OutcomeElementsEnrollmentFutureGeneticGoalsHealth StatusHumanImage CytometryImmuneImmune responseImmune systemImmunityImmunologic FactorsImmunological ModelsImmunologyImmunophenotypingIn VitroIndividualInfectionInfluenza vaccinationInfrastructureInstitutesInstitutionInterventionLaboratoriesLyme DiseaseMapsMathematicsMethodsMicrobeMolecularMolecular ProfilingMusicOutcomeOutputPathogenesisPathway interactionsPatientsPopulationPredispositionRecordsResearchResearch PersonnelResearch Project GrantsResistanceResolutionResourcesSamplingScientistSerumSeveritiesStandardizationSystemSystemic diseaseSystems BiologyTechnologyTissuesTranslatingUniversity HospitalsViralVirulenceWest Nile virusWorkage effectarthropod-bornebasebody systemclinically relevantcohortcomorbiditydata integrationdata managementexperiencegene functionhuman diseasehuman pathogenimmune functionmetabolomicsnanoscalenew technologynovelpathogenpathogenic bacteriapathogenic viruspatient populationpatient stratificationprogramsrecruitresponsesharing platformsuccesstick transmissiontooltranscriptome sequencingvector-borne infection
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The overall goal of the Human Immunology Project Consortium (HIPC) program is to capitalize on recent
advances in immune profiling methods in order to create a novel public resource that characterizes diverse
states of the human immune system. We propose to contribute to this program through deep
interrogation and a broad systems approach that will identify molecular signatures of divergent
human immune responses to infections. The three projects that comprise our U19 each leverage a
common experimental infrastructure to focus on a different infectious diseases: the Lyme disease
spirochete Borrelia burgdorferi, emerging arthropod-borne West Nile virus, and effects of aging on
vaccination against influenza. Our goal is to delineate human immune signatures that are associated with
the divergent manifestations in the population, using well-defined patient cohorts and a multidimensional
analytical approach to quantitatively assess primary human immune cell function. Our program employs
cutting-edge immune profiling such as multidimensional profiling by CyTOF, metabolomics, nanoscale
technologies such as MuSIC (MultiSpectral Imaging Cytometry), and RNA-seq on single cells that will
inform a systems approach to elucidate the biologic signatures defining immune responsiveness.
Commonalities between the responses in different tissues, and to the different infection types, will be
determined by quantifying signature enrichments, and by identifying conserved active sub-networks in this
immune-specific functional network.
This collaborative U19 takes advantage of enormous strengths across our institutions to tackle a
challenging issue in human immunology. The investigators in this proposal have established collaborations,
regular interactions, and a track record of shared success. Our three research projects are supported by
shared cores for Administration, Data Management and Analysis, Single Cell Immunophenotyping, and
Clinical Recruitment. The united goal of these varied approaches is to define elements of the immune
response that contribute to divergent infection outcomes. This multifactorial, wide-angle view of the immune
response will be compiled employing the expertise of each individual approach for Systems Modeling from
deep interrogation of three sets of stratified patient cohorts. The output of this functional systems
immunology approach will be definitions of human immune signatures following multiple forms of infectious
challenges with the ultimate goal of defining future targets for intervention and predicting susceptibility or
resistance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting T cell dysfunction in glioblastoma: A proof-of-concept Phase 0/I trial of anti-TIGIT antibody AB154 in combination with anti-PD1 antibody AB122
-
批准号:10346649
-
项目类别:
-
资助金额:$69.51万
-
财政年份:2022
-
负责人:David A. Hafler
-
依托单位:
Targeting T cell dysfunction in glioblastoma: A proof-of-concept Phase 0/I trial of anti-TIGIT antibody AB154 in combination with anti-PD1 antibody AB122
-
批准号:10573141
-
项目类别:
-
资助金额:$67.34万
-
财政年份:2022
-
负责人:David A. Hafler
-
依托单位:
Systems Immune Profiling of Divergent Responses to Infection
-
批准号:10265709
-
项目类别:
-
资助金额:$107.73万
-
财政年份:2020
-
负责人:David A. Hafler
-
依托单位:
Systems Immune Profiling of Divergent Responses to Infection
-
批准号:10205567
-
项目类别:
-
资助金额:$45.42万
-
财政年份:2020
-
负责人:David A. Hafler
-
依托单位:
COVID-19 Supplement: Systems Immune Profiling of Divergent Responses to Infection
-
批准号:10265708
-
项目类别:
-
资助金额:$64.28万
-
财政年份:2020
-
负责人:David A. Hafler
-
依托单位:
Core for COVID-19 Cohort IMPACC
-
批准号:10265707
-
项目类别:
-
资助金额:$95.5万
-
财政年份:2020
-
负责人:David A. Hafler
-
依托单位:
Yale Clinical Neuroscientist Training Program
-
批准号:10333938
-
项目类别:
-
资助金额:$10.16万
-
财政年份:2012
-
负责人:David A. Hafler
-
依托单位:
Yale Clinical Neuroscientist Training Program
-
批准号:10210303
-
项目类别:
-
资助金额:$10.28万
-
财政年份:2012
-
负责人:David A. Hafler
-
依托单位:
The role of the innate immune system on Treg reprogramming in human autoimmune di
-
批准号:8495933
-
项目类别:
-
资助金额:$73.41万
-
财政年份:2012
-
负责人:David A. Hafler
-
依托单位:
Yale Clinical Neuroscientist Training Program
-
批准号:8331031
-
项目类别:
-
资助金额:$7.56万
-
财政年份:2012
-
负责人:David A. Hafler
-
依托单位:
Yale Clinical Neuroscientist Training Program
-
批准号:8573944
-
项目类别:
-
资助金额:$16.36万
-
财政年份:2012
-
负责人:David A. Hafler
-
依托单位:
Multimensional Robotic Flow Platform
-
批准号:8376939
-
项目类别:
-
资助金额:$74.27万
-
财政年份:2012
-
负责人:David A. Hafler
-
依托单位:
The role of the innate immune system on Treg reprogramming in human autoimmune di
-
批准号:9090023
-
项目类别:
-
资助金额:$72.19万
-
财政年份:2012
-
负责人:David A. Hafler
-
依托单位:
Yale Clinical Neuroscientist Training Program
-
批准号:8839375
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2012
-
负责人:David A. Hafler
-
依托单位:
Yale Clinical Neuroscientist Training Program
-
批准号:8628198
-
项目类别:
-
资助金额:$8.75万
-
财政年份:2012
-
负责人:David A. Hafler
-
依托单位:
The role of the innate immune system on Treg reprogramming in human autoimmune di
-
批准号:8373995
-
项目类别:
-
资助金额:$81.56万
-
财政年份:2012
-
负责人:David A. Hafler
-
依托单位:
The role of the innate immune system on Treg reprogramming in human autoimmune di
-
批准号:8874095
-
项目类别:
-
资助金额:$74.24万
-
财政年份:2012
-
负责人:David A. Hafler
-
依托单位:
Yale Clinical Neuroscientist Training Program
-
批准号:8436212
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:David A. Hafler
-
依托单位:
Yale Clinical Neuroscientist Training Program
-
批准号:8874320
-
项目类别:
-
资助金额:$5.65万
-
财政年份:2012
-
负责人:David A. Hafler
-
依托单位:
Yale Clinical Neuroscientist Training Program
-
批准号:9091654
-
项目类别:
-
资助金额:$5.71万
-
财政年份:2012
-
负责人:David A. Hafler
-
依托单位:
海外基金